Isabelle Soubeyran

Bordeaux, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 97 publications

Corrigendum to "Management and survival of patients with cancer of unknown primary discussed by a French national multidisciplinary tumour board: a retrospective analysis" The Lancet Regional Health - Europe, Volume 60, January 2026, 101524.

Corrigendum to "Management and survival of patients with cancer of unknown primary discussed by a French national multidisciplinary tumour board: a retrospective analysis" The Lancet Regional Health - Europe, Volume 60, January 2026, 101524.

Journal: The Lancet regional health. Europe

Published: July 30, 2026

Prediction of Mutations and Outcome in Gastrointestinal Stromal Tumors with Deep Learning: A Multicenter, Multinational Study.

Prediction of Mutations and Outcome in Gastrointestinal Stromal Tumors with Deep Learning: A Multicenter, Multinational Study.

Journal: medRxiv : the preprint server for health sciences

Published: February 12, 2026

Deep Learning Predicts Mutations and Outcomes in Gastrointestinal Stromal Tumors.

Deep Learning Predicts Mutations and Outcomes in Gastrointestinal Stromal Tumors.

Journal: Cancer research

Published: January 12, 2026

Deep Learning Predicts Mutations and Outcomes in Gastrointestinal Stromal Tumors from Whole-Slide Images.

Deep Learning Predicts Mutations and Outcomes in Gastrointestinal Stromal Tumors from Whole-Slide Images.

Journal: Cancer research

Published: January 12, 2026

Genetic variant interpretation in tumours in the French national ring trials Gen&Tiss - main criteria of improvement.

Genetic variant interpretation in tumours in the French national ring trials Gen&Tiss - main criteria of improvement.

Journal: Virchows Archiv : an international journal of pathology

Published: September 05, 2025

Management and survival of patients with cancer of unknown primary discussed by a French national multidisciplinary tumour board: a retrospective analysis.

Management and survival of patients with cancer of unknown primary discussed by a French national multidisciplinary tumour board: a retrospective analysis.

Journal: The Lancet regional health. Europe

Published: July 07, 2025

Molecular analysis of lung adenocarcinomas from the SAFIR02-Lung cohort reveals new metastasis-associated copy-number alterations including frequent mutant-specific KRAS-allelic imbalance and identifies CDKN2A homozygous deletions as an independent biomarker of poor prognosis.

Molecular analysis of lung adenocarcinomas from the SAFIR02-Lung cohort reveals new metastasis-associated copy-number alterations including frequent mutant-specific KRAS-allelic imbalance and identifies CDKN2A homozygous deletions as an independent biomarker of poor prognosis.

Journal: British journal of cancer

Published: February 11, 2025

Uterine Sarcomas With Recurrent KDM2B Gene Fusions: Three Cases of a Possible Novel Subtype of High-Grade Endometrial Stromal Sarcoma.

Uterine Sarcomas With Recurrent KDM2B Gene Fusions: Three Cases of a Possible Novel Subtype of High-Grade Endometrial Stromal Sarcoma.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: January 02, 2025

Deciphering Pseudoendocrine Sarcoma: A Clinicopathological, Molecular, and Epigenetic Study Suggesting Biological Links With Solid Pseudopapillary Neoplasm of the Pancreas.

Deciphering Pseudoendocrine Sarcoma: A Clinicopathological, Molecular, and Epigenetic Study Suggesting Biological Links With Solid Pseudopapillary Neoplasm of the Pancreas.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: December 05, 2024

Challenges of a tailored immunohistochemistry algorithm for uterine leiomyosarcoma: an integrated analysis of leiomyomas with bizarre nuclei and fumarate hydratase (FH) deficiency.

Challenges of a tailored immunohistochemistry algorithm for uterine leiomyosarcoma: an integrated analysis of leiomyomas with bizarre nuclei and fumarate hydratase (FH) deficiency.

Journal: Histopathology

Published: November 04, 2024

Genomic landscape of estrogen receptor-positive HER2-negative advanced breast cancer with acquired resistance to aromatase inhibitors: Identification of an ESR1 alteration-related gene signature.

Genomic landscape of estrogen receptor-positive HER2-negative advanced breast cancer with acquired resistance to aromatase inhibitors: Identification of an ESR1 alteration-related gene signature.

Journal: British journal of cancer

Published: November 03, 2024

Extensive molecular profiling of KRAS wild-type as compared to KRAS mutated pancreatic ductal adenocarcinoma on 318 patients.

Extensive molecular profiling of KRAS wild-type as compared to KRAS mutated pancreatic ductal adenocarcinoma on 318 patients.

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 24, 2024

Showing 1-12 of 97

Last Updated: 09/26/2026